n-(1-methyl-2-phenylethyl)adenosine has been researched along with bucladesine in 1 studies
| Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
|---|---|---|---|---|---|
| 134 | 0 | 4 | 9,775 | 13 | 210 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, Y; Narita, T; Okajima, F; Sho, K | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and bucladesine
| Article | Year |
|---|---|
An adenosine receptor agonist-induced modulation of TSH-dependent cell growth in FRTL-5 thyroid cells mediated by inhibitory G protein, Gi.
Topics: Adenosine; Bucladesine; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; G1 Phase; GTP-Binding Protein alpha Subunits, Gi-Go; Pertussis Toxin; Purinergic P1 Receptor Agonists; Resting Phase, Cell Cycle; S Phase; Thymidine; Thyroid Gland; Thyrotropin; Virulence Factors, Bordetella | 1999 |